Kestra Medical Technologies develops wearable medical devices and digital healthcare solutions. The company reported strong commercial momentum and attractive unit economics, according to CEO Brian Webster, and plans to continue investing in growth strategies. The newly arranged term loan was used in part to retire a prior $45 million term loan and to cover fees and expenses. Kestra has access to staged tranches of capital that include funded and optional amounts, plus an acquisition-focused uncommitted tranche subject to lender consent. The financing structure includes interest-only payments for the first 48 months (with a possible 12-month extension tied to a revenue milestone) and interest at SOFR plus 5.5% with a SOFR floor of 3.25%.

Total raised

$271M

Funding rounds

2

Latest round

Debt Financing

Latest activity

Jul 2026